Spending for inflammatory drugs like AbbVie's Humira and Amgen's Enbrel rose, while hepatitis C drugs showed decline.
FDA solicits public comment to study online character space limit; Biogen's Spinraza shows positive results in SMA study; Valeant cuts earnings forecast
When drug costs started to soar, PBMs turned to formulary exclusions — and the industry is still feeling the pinch.
Walgreens Boots partners with PBM; Clinton proposes mental health plan; BI and Qualcomm to develop connected inhaler
The implementation of a broad outcomes-based pricing scheme is a wildly, almost gratuitously complicated project.